[1]
Nafrialdi, N., Handini, N.M., Instiaty, I. and Wijaya, I.P. 2018. A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome. Medical Journal of Indonesia. 27, 4 (Dec. 2018), 262–70. DOI:https://doi.org/10.13181/mji.v27i4.3024.